BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Naida JD, Davis MA, Lawrence TS. The effect of activation of wild-type p53 function on fluoropyrimidine-mediated radiosensitization. International Journal of Radiation Oncology*Biology*Physics 1998;41:675-80. [DOI: 10.1016/s0360-3016(98)00134-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Axelson MD, Davis MA, Ethier SP, Lawrence TS. HPV16-E7 expression causes fluorodeoxyuridine-mediated radiosensitization in SW620 human colon cancer cells. Neoplasia 1999;1:177-82. [PMID: 10933053 DOI: 10.1038/sj.neo.7900012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
2 Sasaki K, Tsuno NH, Sunami E, Kawai K, Shuno Y, Hongo K, Hiyoshi M, Kaneko M, Murono K, Tada N, Nirei T, Kitayama J, Takahashi K, Nagawa H. Radiosensitization of human breast cancer cells to ultraviolet light by 5-fluorouracil. Oncol Lett 2011;2:471-6. [PMID: 22866105 DOI: 10.3892/ol.2011.261] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
3 Tsuchiya T, Matsumoto K, Miyazaki T, Yamaguchi H, Yamazaki T, Sano I, Fukuoka J, Nakamura Y, Yamasaki N, Nagayasu T. Concurrent chemoradiotherapy using cisplatin and S-1, followed by surgery for stage II/IIIA non-small cell lung cancer. Gen Thorac Cardiovasc Surg 2019;67:537-43. [PMID: 30673966 DOI: 10.1007/s11748-018-01058-3] [Reference Citation Analysis]